S'abonner

Missed opportunities for HPV immunization among young adult women - 01/03/18

Doi : 10.1016/j.ajog.2017.11.602 
Carlos R. Oliveira, MD a, , Robert M. Rock, BA b, Eugene D. Shapiro, MD a, Xiao Xu, PhD c, Lisbet Lundsberg, PhD c, Liye B. Zhang, BA d, Aileen Gariepy, MD c, Jessica L. Illuzzi, MD, MHS c, Sangini S. Sheth, MD, MPH c
a Departments of Pediatrics and Medicine, School of Medicine, Yale University, New Haven 
b School of Medicine, Yale University, New Haven 
c Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, Yale University, New Haven 
d Frank H. Netter School of Medicine, Quinnipiac University, North Haven, CT 

Corresponding author: Carlos R. Oliveira, MD.

Abstract

Background

Despite the availability of a safe and efficacious vaccine against human papillomavirus, uptake of the vaccine in the United States is low. Missed clinical opportunities to recommend and to administer human papillomavirus vaccine are considered one of the most important reasons for its low uptake in adolescents; however, little is known about the frequency or characteristics of missed opportunities in the young adult (18–26 years of age) population.

Objective

The objective of the study was to assess both the rates of and the factors associated with missed opportunities for human papillomavirus immunization among young adult women who attended an urban obstetrics and gynecology clinic.

Study Design

In this cross-sectional study, medical records were reviewed for all women 18–26 years of age who were underimmunized (<3 doses) and who sought care from Feb. 1, 2013, to January 31, 2014, at an urban, hospital-based obstetrics and gynecology clinic. A missed opportunity for human papillomavirus immunization was defined as a clinic visit at which the patient was eligible to receive the vaccine and a dose was due but not administered. Multivariable logistic regression was used to test associations between sociodemographic variables and missed opportunities.

Results

There were 1670 vaccine-eligible visits by 1241 underimmunized women, with a mean of 1.3 missed opportunities/person. During the study period, 833 of the vaccine eligible women (67.1%) had at least 1 missed opportunity. Overall, the most common types of visits during which a missed opportunity occurred were postpartum visits (17%) or visits for either sexually transmitted disease screening (21%) or contraception (33%). Of the patients with a missed opportunity, 26.5% had a visit at which an injectable medication or a different vaccine was administered. Women who identified their race as black had higher adjusted odds of having a missed opportunity compared with white women (adjusted odds ratio, 1.61 [95% confidence interval, 1.08–2.41], P < .02). Women who reported a non-English- or non-Spanish-preferred language had lower adjusted odds of having a missed opportunity (adjusted odds ratio, 0.25 [95% confidence interval, 0.07–0.87], P = .03). No other patient characteristics assessed in this study were significantly associated with having a missed opportunity.

Conclusion

A majority of young-adult women in this study had missed opportunities for human papillomavirus immunization, and significant racial disparity was observed. The greatest frequency of missed opportunities occurred with visits for either contraception or for sexually transmitted disease screening.

Le texte complet de cet article est disponible en PDF.

Key words : cervical cancer prevention, human papillomavirus, preventative medicine, vaccination


Plan


 The views expressed herein are those of the authors and do not necessarily represent the official views of the National Institutes of Health.
 This study was supported, in part, from grants from the American Cancer Society (Dr Oliveira), the Robert E. Leet and Clara Guthrie Patterson Trust (Dr Oliveira) and by Clinical and Translational Science Award grant numbers KL2 TR001862 (Drs Sheth and Shapiro), TL1TR001864 (Drs Oliveira and Shapiro), and UL1TR000142 (Dr Shapiro) from the National Center for Advancing Translational Science at the National Institutes of Health (NIH) and the NIH roadmap for Medical Research. The contents herein are solely the responsibility of the authors and do not necessarily represent the official views of National Institutes of Health.
 The authors report no conflict of interest.
 Cite this article as: Oliveira CR, Rock RM, Shapiro ED, et al. Missed opportunities for HPV immunization among young adult women. Am J Obstet Gynecol 2018;218:326.e1-7.


© 2017  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 218 - N° 3

P. 326.e1-326.e7 - mars 2018 Retour au numéro
Article précédent Article précédent
  • Spectrum of symptoms in women diagnosed with endometriosis during adolescence vs adulthood
  • Amy D. DiVasta, Allison F. Vitonis, Marc R. Laufer, Stacey A. Missmer
| Article suivant Article suivant
  • Trichomonas vaginalis is most frequently detected in women at the age of peri-/premenopause: an unusual pattern for a sexually transmitted pathogen
  • Shlomo M. Stemmer, Eli Mordechai, Martin E. Adelson, Scott E. Gygax, David W. Hilbert

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.